Delaware
|
001-38613
|
26-1756290
|
(State or Other Jurisdiction of Incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
9540 Towne Centre Drive, Suite 100
San Diego, California
|
92121
|
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading
Symbol(s)
|
Name of each exchange
on which registered
|
Common Stock, $0.0001 par value per share
|
BNGO
|
The Nasdaq Stock Market LLC
|
Warrants to purchase Common Stock
|
BNGOW
|
The Nasdaq Stock Market LLC
|
Item 5.07 |
Submission of Matters to a Vote of Security Holders.
|
Name
|
Votes For
|
Votes Withheld
|
Broker Non-Votes
|
Christopher Twomey
|
59,405,915
|
6,288,064
|
74,987,886
|
Yvonne Linney, Ph.D.
|
60,541,510
|
5,152,469
|
74,987,886
|
Votes For
|
Votes Against
|
Abstentions
|
135,470,333
|
879,849
|
4,331,683
|
Bionano Genomics, Inc.
|
||
Date: June 11, 2021
|
By:
|
/s/ R. Erik Holmlin, Ph.D.
|
R. Erik Holmlin, Ph.D.
|
||
President and Chief Executive Officer
(Principal Executive Officer)
|